TREX-1 Antibodies

Santa Cruz Biotechnology features a diverse variety of TREX-1 monoclonal antibodies for research focused on understanding TREX-1's role in cellular processes. TREX-1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TREX-1, or three prime repair exonuclease 1, is a crucial enzyme involved in the degradation of cytosolic DNA, playing a significant role in maintaining genomic stability and preventing autoimmune responses. Its function is essential during viral infections and cellular stress, as it helps regulate the immune response by controlling DNA levels in the cytoplasm. Dysregulation of TREX-1 has been linked to various diseases, including autoimmune disorders and cancer, making it a key focus in both basic and translational research. Understanding TREX-1's molecular mechanisms can provide valuable insights into disease pathways and potential therapeutic strategies. Investigating TREX-1's cellular distribution and protein interactions can reveal new aspects of its biological functions. Research with TREX-1 monoclonal antibodies continues to advance our understanding of immune system regulation and DNA metabolism. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge and developing potential therapeutic approaches.